Q1 2024 Viridian Therapeutics Inc Earnings Call Transcript
Welcome to the Veridian Therapeutics First Quarter 2024 a conference call. (Operator Instructions). As a reminder, this conference call is being recorded. I would now like to hand the call over to Ms. Louisa Stone Manager of Investor Relations at. Viridian, Please go ahead.
Thank you, and welcome, everyone to our fourth first quarter 2024 earnings conference call. The press release reporting our financial results and corporate updates as available on the Investors page of our corporate website at www.veridian therapeutics.com.
Joining me on the call this morning are Steve Mahoney, our President and CEO, Thomas Ciulla, our Chief Medical Officer, and Shan Wu, our Chief Business Officer.
Before we begin, I would like to remind everyone that this conference call and webcast will contain forward looking statements regarding our financial outlook in addition to regulatory product development and commercialization plans and research activities. These statements are subject to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |